Retatrutide appears to be a new medication in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By activating these receptors, Retatrutide controls cravings, {promotesenergy expenditure, and ultimately results in significant reduction in body m